Programmed Cell Death 2-Like (PDCD2L) Peptide
-
- Target See all PDCD2L products
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FACACPGCST GGARSWKVFR SQCLQVPERE AQDAQKQGNS LAAEDWCEGA
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PDCD2 L antibody,
Alternative Names: PDCD2L control peptide, PDCD2L antibody Blocking Peptide, Anti-PDCD2L Blocking Peptide, programmed cell death 2-like Blocking Peptide, MGC13096 Blocking Peptide, PDCD2L, PDCDL-2, PDCDL 2, PDCDL-2 Blocking Peptide, PDCDL 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PDCD2L (Programmed Cell Death 2-Like (PDCD2L))
- Background
- Over expression of PDCD2L attenutates TNF-alpha release in Daudi cells. PDCD2L over-expression restrained proliferation of HEK293T cells. DNA/flow cytometry analysis showed that the over-expression of PDCD2L severely delays cell cycle progression at S phase. These all suggest that PDCD2L might play a role in apoptosis.
- Molecular Weight
- 39 kDa
-